Imprivata Appoints Industry Veteran as Vice President for Its North American Healthcare Group
Seasoned Healthcare Executive to Help Imprivata Expand Leadership by Driving Continued Growth in the North American Market
LEXINGTON, MA-May 4, 2010-Imprivata®, Inc., the company that simplifies and secures user access, today announced the appointment of Jim Whelan to vice president of the company’s North American Healthcare Group. Whelan brings a wealth of healthcare experience to Imprivata, which earlier this year announced the launch of a new Global Healthcare Division. In this new position, Whelan will be charged with building on the company’s momentum which includes work with more than 500 hospitals, one million healthcare users and strategic relationships with leading health information systems (HIS) vendors.
Whelan joins Imprivata with a proven track record in building and leading high-performance sales organizations within the healthcare sector. Most recently, he was a senior vice president at the Institute for Healthmetrics (IHM), a quality and performance improvement reporting solution designed for hospitals and health systems. Additional healthcare experience includes his role as corporate executive director of business development at Superior Consultant Company, a leading healthcare IT consulting firm that was acquired by ACS, then Xerox.
“Since day one, Imprivata has dedicated itself to helping hospitals bridge the gap between security and clinical productivity, a principle that has been eagerly embraced by our more than 500 healthcare customers,” said Omar Hussain, president and CEO of Imprivata. “With his sound understanding of the industry and proven ability to lead, Jim is well-suited to spearhead our new Healthcare Division. Under his leadership, Imprivata will extend its reach to millions of healthcare users, helping them to succeed by making patient data easily accessible, enforcing patient privacy and deploying transparent security.”
“Healthcare organizations face unique and unprecedented challenges, and subsequently seek solutions that help them on multiple fronts, and ultimately improve the quality of care,” said Jim Whelan. “I am excited to join the Imprivata team and show a growing number of organizations that security and patient care are not mutually exclusive and that in fact, they are challenges that can be addressed swiftly and simultaneously to ensure optimal patient outcomes.”
Imprivata’s Global Healthcare Division was announced in February of 2010 and is committed to helping hospitals and healthcare organizations improve patient outcomes by simplifying and securing user access to patient health information. Imprivata OneSign®, Imprivata’s flagship solution, provides healthcare organizations with rapid single sign-on and strong authentication for all leading HIS vendors, including Cerner, Epic, Healthland, McKesson, MEDITECH, Siemens Healthcare, as well as all other types of applications. Key Imprivata OneSign features include OneSign FastPass, OneSign ProveID, OneSign Secure Walk Away, Citrix/XenApp & terminal services support, shared workstations and fast user switching, built-in support for a broad range of authentication and multiple card types, self-service password reset and seamless integration with context management solutions.
Imprivata is the leading independent vendor focused on simplifying and securing user access. By strengthening user authentication, streamlining application access and simplifying compliance reporting across multiple computing environments, customers realize substantial IT Help Desk and administration cost savings, while achieving the security standards they demand.
Imprivata has received numerous product awards and top review ratings from leading industry publications and analysts. Headquartered in Lexington, Mass., Imprivata partners with over 200 resellers, and serves the access security needs of more than 900 customers around the world. For more information, please visit www.imprivata.com.
Imprivata is a registered trademark of Imprivata, Inc. in the USA and other countries. All other product or company names mentioned are the property of their respective owners.